Lx2-32c, a novel semi-synthetic taxane, exerts antitumor activity against prostate cancer cells in vitro and in vivo
Tubulin has been shown to be an effective target for the development of cytotoxic agents against prostate cancer. Previously, we reported that Lx2-32c is an anti-tubulin agent with high binding affinity to tubulin. In this study, we investigated the potential of Lx2-32c to act as an effective cytoto...
Saved in:
Main Authors: | Guangyao Lv (Author), Dengjun Sun (Author), Jingwen Zhang (Author), Xiaoxia Xie (Author), Xiaoqiong Wu (Author), Weishuo Fang (Author), Jingwei Tian (Author), Chunhong Yan (Author), Hongbo Wang (Author), Fenghua Fu (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2017-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Determination of 6258-70, a new semi-synthetic taxane, in rat plasma and tissues: Application to the pharmacokinetics and tissue distribution study
by: Simin Zhao, et al.
Published: (2016) -
The Synthetic Cannabinoid URB447 Exerts Antitumor and Antimetastatic Effect in Melanoma and Colon Cancer
by: Aitor Benedicto, et al.
Published: (2022) -
LPM3770277, a Potent Novel CDK4/6 Degrader, Exerts Antitumor Effect Against Triple-Negative Breast Cancer
by: Jiahao Qiu, et al.
Published: (2022) -
Neoadjuvant chemotherapy outcome with taxane-based versus non-taxane protocols in gastric cancer
by: Shirin Kianersi, et al.
Published: (2023) -
Editorial: Exploring the therapeutic effects of synthetic, semi-synthetic and naturally derived compounds against cancer
by: Liang Feng, et al.
Published: (2023)